Isosteviol prevents the prolongation of action potential in hypertrophied cardiomyoctyes by regulating transient outward potassium and L-type calcium channels

Biochimica et Biophysica Acta - Biomembranes

Volumn 1859, Issue 10, 2017, Pages 1872-1879

  Fan, Zhuo ^a   Lv, Nanying ^a   Luo, Xiao ^a   Tan, Wen ^b  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b GUANGDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Cardiac hypertrophy; Isosteviol; L type calcium channel; Transient outward potassium channel

Indexed keywords

CALCIUM CHANNEL L TYPE; ISOSTEVIOL; MESSENGER RNA; POTASSIUM CHANNEL; STEVIOSIDE; UNCLASSIFIED DRUG; GLUCOSIDE; KAURANE DERIVATIVE; POTASSIUM;

ACTION POTENTIAL DURATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; CURRENT DENSITY; GENETIC TRANSCRIPTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; ISOPROTERENOL-INDUCED CARDIAC HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ACTION POTENTIAL; ANIMAL; CARDIAC MUSCLE; CARDIOMEGALY; DRUG EFFECTS; HEART ARRHYTHMIA; METABOLISM; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM CHANNELS, L-TYPE; CARDIOMEGALY; DITERPENES, KAURANE; GLUCOSIDES; MYOCARDIUM; MYOCYTES, CARDIAC; POTASSIUM; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 85021653322     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2017.04.011     Document Type: Article

References (42)

1. Haider, A.W., Larson, M.G., Benjamin, E.J., Levy, D., Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J. Am. Coll. Cardiol. 32 (1998), 1454–1459.
2. Kohya, T., Kimura, S., Myerburg, R.J., Bassett, A.L., Susceptibility of hypertrophied rat hearts to ventricular fibrillation during acute ischemia. J. Mol. Cell. Cardiol. 20 (1988), 159–168.
3. Pye, M.P., Cobbe, S.M., Mechanisms of ventricular arrhythmias in cardiac failure and hypertrophy. Cardiovasc. Res. 26 (1992), 740–750.
4. Boyden, P.A., Jeck, C.D., Ion channel function in disease. Cardiovasc. Res. 29 (1995), 312–318.
5. Wickenden, A.D., Japrielian, R., Kassiri, Z., Tsoporis, J.N., Tsushima, R., Fishman, G.I., Backx, P.H., The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc. Res. 37 (1998), 312–323.
6. Nabauer, M., Kaab, S., Potassium channel down-regulation in heart failure. Cardiovasc. Res. 37 (1998), 324–334.
7. Swynghedauw, B., Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79 (1999), 215–262.
8. Amin, A.S., Tan, H.L., Wilde, A.A., Cardiac ion channels in health and disease. Heart Rhythm. 7 (2010), 117–126.
9. Chae, J.E., Kim, H.S., Ahn, D.S., Park, W.K., Ionic mechanisms of desflurane on prolongation of action potential duration in rat ventricular myocytes. Yonsei Med. J. 53 (2012), 204–212.
10. Danik, S., Cabo, C., Chiello, C., Kang, S., Wit, A.L., Coromilas, J., Correlation of repolarization of ventricular monophasic action potential with ECG in the murine heart. Am. J. Physiol. Heart Circ. Physiol. 283 (2002), H372–H381.
11. Coulombe, A., Momtaz, A., Richer, P., Swynghedauw, B., Coraboeuf, E., Reduction of calcium independent transient outward potassium current density in DOCA salt hypertrophied rat ventricular myocytes. Pfluegers Arch. 427 (1994), 47–55.
12. Bénitah, J.P., Gomez, A.M., Bailly, P., Da Ponte, J.P., Berson, G., Delgado, C., Lorente, P., Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts. J. J. Physiol. 469 (1993), 111–138.
13. + channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circ. Res. 79 (1996), 669–675.
14. + channel subunit in the mouse heart. Circ. Res. 85 (1999), 1067–1076.
15. Barry, D.M., Xu, H., Schuessler, R.B., Nerbonne, J.M., Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 α subunit. Circ. Res. 83 (1998), 560–567.
16. + channel subunit mRNAs in ventricles of renovascular hypertensive rats. Circ. Res. 81 (1997), 533–539.
17. Geuns, J.M.C., Stevioside. Phytochemistry 64 (2003), 913–921.
18. Hsu, Y.H., Liu, J.C., Kao, P.F., Chan, P., Antihypertensive effect of stevioside in different strains of hypertensive rats. Chin. Med. J. 65 (2002), 1–6.
19. Hsieh, M.H., Chan, P., Sue, Y.M., Liu, J.C., Liang, T.H., Huang, T.Y., Tomlinson, B., Sum Chow, M.S., Kao, P.F., Chen, Y.J., Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study. Clin. Ther. 25 (2003), 2797–2808.
20. Yasukawa, K., Kitanaka, S., Seo, S., Inhibitory effect of stevioside on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Biol. Pharm. Bull. 25 (2002), 1488–1490.
21. Liu, J.C., Kao, P.F., Hsieh, M.H., Chen, Y.J., Chan, P., The antihypertensive effects of stevioside derivative isosteviol in spontaneously hypertensive rats. Acta Cardiol. Sin. 17 (2001), 133–140.
22. Ma, J., Ma, Z., Wang, J., Milne, R.W., Xu, D., Davey, A.K., Evans, A.M., Isosteviol reduces plasma glucose levels in the intravenous glucose tolerance test in Zucker diabetic fatty rats. Diabetes Obes. Metab. 9 (2007), 597–599.
23. Xu, D., Zhang, S., Foster, D.J.R., Wang, J., The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heart. Clin. Exp. Pharmacol. Physiol. 34 (2007), 488–493.
24. Xu, D., Li, Y., Wang, J., Davey, A.K., Zhang, S., Evans, A.M., The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury. Life Sci. 80 (2007), 269–274.
25. Fan, Z., Wen, T., Chen, Y.X., Huang, L.J., Lin, W., Yin, C.X., Tan, W., Isosteviol sensitizes sarcKATP channels towards Pinacidil and potentiates mitochondrial uncoupling of Diazoxide in Guinea pig ventricular myocytes. Oxidative Med. Cell. Longev. 2016 (2016), 1–13.
26. van der Heyden, M.A., Wijnhoven, T.J., Opthof, T., Molecular aspects of adrenergic modulation of the transient outward current. Cardiovasc. Res. 71 (2006), 430–442.
27. Cotella, D., Radicke, S., Bortoluzzi, A., Ravens, U., Wettwer, E., Santoro, C., Sblattero, D., Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of Itochannel complex. Pflugers Arch. 460 (2010), 87–97.
28. Anderson, A.E., Adams, J.P., Qian, Y., Cook, R.G., Pfaffinger, P.J., Sweatt, J.D., Kv4.2 phosphorylation by cyclic AMP-dependent protein kinase. J. Biol. Chem. 275 (2000), 5337–5346.
29. Keung, E.C., Calcium current is increased in isolated adult myocytes from hypertrophied rat myocardium. Circ. Res. 64 (1989), 753–763.
30. Kamp, T.J., Hell, J.W., Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ. Res. 87 (2000), 1095–1102.
31. Yang, L., Liu, G., Zakharov, S.I., Bellinger, A.M., Mongillo, M., Marx, S.O., Protein kinase G phosphorylates Cav1.2 alpha1c and beta2 subunits. Circ. Res. 101 (2007), 465–474.
32. Li, M., He, H.P., Gong, H.Q., Zhang, J., Ma, W.J., Zhou, H., Cao, D.S., Wang, N., Zhang, T.C., NFATc4 and myocardin synergistically up-regulate the expression of LTCC α1C in ET-1-induced cardiomyocytehypertrophy. Life Sci. 155 (2016), 11–20.
33. Han, J.W., Lee, Y.H., Yoen, S.I., Abramowitz, J., Birnbaumer, L., Lee, M.G., Kim, J.Y., Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice. Mol. Cell. Biochem. 421 (2016), 55–65.
34. Chen, Y., Li, Y., Guo, L., Chen, W., Zhao, M., Gao, Y., Wu, A., Lou, L., Wang, J., Liu, X., Xing, Y., Effects of wenxin keli on the action potential and L-type calcium current in rats with transverse aorticconstriction-induced heart failure. Evid. Based Complement. Alternat. Med. 2013 (2013), 1–12.
35. Feng, X.J., Gao, H., Gao, S., Li, Z.M., Li, H., Lu, J., Wang, J.J., Huang, X.Y., Liu, M., Zou, J., Ye, J.T., Liu, P., The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1. Br. J. Pharmacol. 172 (2015), 2852–2863.
36. Mao, H.P., Wang, X.Y., Gao, Y.H., Chang, Y.X., Chen, L., Niu, Z.C., Ai, J.Q., Gao, X.M., Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-κbpathway. J. Ethnopharmacol. 186 (2016), 20–29.
37. Lin, Y., Liu, J.C., Zhang, X.J., Li, G.W., Wang, L.N., Xi, Y.H., Li, H.Z., Zhao, Y.J., Xu, C.Q., Downregulation of the ornithine decarboxylase/polyamine system inhibits angiotensin-induced hypertrophy of cardiomyocytes through the no/cgmp-dependent protein kinase type-i pathway. Cell. Physiol. Biochem. 25 (2010), 443–450.
38. Tsutsui, H., Kinugawa, S., Matsushima, S., Oxidative stress and heart failure. Am. J. Physiol. Heart Circ. Physiol. 301 (2011), H2181–H2190.
39. Wojciechowska, C., Romuk, E., Tomasik, A., Skrzep-Poloczek, B., Nowalany-Kozielska, E., Birkner, E., Jacheć, W., Oxidative stress markers and C-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathy. Mediat. Inflamm. 2014 (2014), 147040–147050.
40. Qin, F., Siwik, D.A., Pimentel, D.R., Morgan, R.J., Biolo, A., Tu, V.H., Kang, Y.J., Cohen, R.A., Colucci, W.S., Cytosolic H2O2 mediates hypertrophy, apoptosis, and decreased SERCA activity in mice with chronic hemodynamic overload. Am. J. Physiol. Heart Circ. Physiol. 306 (2014), H1453–H1463.
41. Song, S., Si, L.Y., Klotho ameliorated isoproterenol-induced pathological changes in cardiomyocytes via the regulation ofoxidative stress. Life Sci. 135 (2015), 118–123.
42. Sun, J.M., Wang, C.M., Guo, Z., Hao, Y.Y., Xie, Y.J., Gu, J., Wang, A.L., Reduction of isoproterenol-induced cardiac hypertrophy and modulation of myocardial connexin43 by a KATP channel agonist. Mol. Med. Rep. 11 (2015), 1845–1850.